| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 628,500 | 509,700 | 404,200 | 490,900 |
| Accounts receivable, net | 625,000 | 582,400 | 543,600 | 524,300 |
| Inventories | 438,000 | 421,100 | 388,700 | 401,200 |
| Other current assets | 131,800 | 167,700 | 121,000 | 134,200 |
| Total current assets | 1,823,300 | 1,680,900 | 1,457,500 | 1,550,600 |
| Property, plant and equipment | 3,232,900 | 3,177,600 | 3,005,400 | 2,990,700 |
| Less accumulated depreciation and amortization | 1,492,300 | 1,455,600 | 1,373,700 | 1,419,700 |
| Property, plant and equipment, net | 1,740,600 | 1,722,000 | 1,631,700 | 1,571,000 |
| Operating lease right-of-use assets | 97,800 | 104,400 | 103,400 | 108,000 |
| Investments in affiliated companies | 220,900 | 224,700 | 211,900 | 217,500 |
| Goodwill | 110,600 | 110,900 | 107,500 | 108,800 |
| Intangible assets, net | 8,900 | 9,700 | 10,000 | 12,300 |
| Deferred income taxes | 27,900 | 29,700 | 26,000 | 37,600 |
| Other noncurrent assets | 75,800 | 70,500 | 70,200 | 69,300 |
| Total assets | 4,105,800 | 3,952,800 | 3,618,200 | 3,675,100 |
| Notes payable and other current debt | - | - | - | 0 |
| Accounts payable | 255,800 | 239,000 | 228,400 | 224,300 |
| Accrued salaries, wages and benefits | 111,800 | 93,400 | 67,800 | 79,600 |
| Income taxes payable | 33,300 | 28,500 | 22,300 | 33,400 |
| Operating lease liabilities | 21,400 | 20,900 | 21,800 | 19,900 |
| Other current liabilities | 213,100 | 222,800 | 186,400 | 159,300 |
| Total current liabilities | 635,400 | 604,600 | 526,700 | 516,500 |
| Long-term debt | 202,700 | 202,600 | 202,600 | 202,600 |
| Deferred income taxes | 22,800 | 23,000 | 21,300 | 9,400 |
| Pension and other postretirement benefits | 31,100 | 30,800 | 28,600 | 30,200 |
| Operating lease liabilities | 73,500 | 79,800 | 78,800 | 82,300 |
| Deferred compensation benefits | 13,500 | 12,500 | 11,400 | 15,200 |
| Other long-term liabilities | 75,300 | 70,400 | 65,700 | 66,800 |
| Total liabilities | 1,054,300 | 1,023,700 | 935,100 | 923,000 |
| Preferred stock, 3.0million shares authorized 0 shares issued and outstanding | 0 | 0 | 0 | 0 |
| Common stock, par value 0.25 per share 200.0 million shares authorized shares issued september30, 2025 - 75.3million, december31, 2024 - 75.3 million shares outstanding september30, 2025 - 71.9million, december31, 2024 - 72.3 million | 18,800 | 18,800 | 18,800 | 18,800 |
| Capital in excess of par value | 0 | 0 | 1,800 | 23,300 |
| Retained earnings | 4,262,400 | 4,139,200 | 4,031,200 | 3,856,900 |
| Accumulated other comprehensive loss | -102,300 | -88,700 | -205,500 | -136,300 |
| Treasury stock, at cost (september30, 2025 - 3.4million shares, december31, 2024 - 3.0 million shares) | 1,127,400 | 1,140,200 | 1,163,200 | 1,010,600 |
| Total equity | 3,051,500 | 2,929,100 | 2,683,100 | 2,752,100 |
| Total liabilities and equity | 4,105,800 | 3,952,800 | 3,618,200 | 3,675,100 |
WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST)